The Blue Pill & Pharma : A Risky Investment?

The story of Viagra, and its effect on the medical landscape, presents a tricky case for analysts. Initially a phenomenal success, generating billions in sales, the intellectual property expiration has allowed the possibility for competing versions, substantially eroding sales volume. While major

read more